Torrent Pharmaceuticals a has reported result for first quarter ended June 30, 2025 (Q1FY26).
The company has reported 17.48% rise in its net profit at Rs 551 crore for the quarter ended June 30, 2025 as compared to Rs 469 crore for the same quarter in the previous year. The total income of the company increased by 6.18% at Rs 2,611 crore for Q1FY26 as compared to Rs 2,459 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 19.91% rise in net profit at Rs 548 crore for Q1FY26 as compared to Rs 457 crore for the same quarter in the previous year. The total income of the company increased by 8.95% at Rs 3,141 crore for Q1FY26 as compared to Rs 2,883 crore for the corresponding quarter previous year.
